Basic Information
MenQuadfi
49281-590
Regulatory Information
49281-590
BLA125701
C73585
May 23, 2025
USA
These highlights do not include all the information needed to use MENQUADFI® safely and effectively. See full prescribing information for MENQUADFI. MenQuadfi, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine injection, for intramuscular use Initial U.S. Approval: 2020
VACCINE LABEL
14
Company Information
086723285
Active Ingredients
Quantity: 10 ug in 0.5 mL
Code: T4GYX3110D
Class Code: ACTIB
Quantity: 10 ug in 0.5 mL
Code: ZT89E5A103
Class Code: ACTIB
Quantity: 10 ug in 0.5 mL
Code: 4WAN8PQK15
Class Code: ACTIB
Quantity: 10 ug in 0.5 mL
Code: L77OK410KW
Class Code: ACTIB
SODIUM CHLORIDE
Quantity: 3.35 mg in 0.5 mL
Code: 451W47IQ8X
Class Code: IACT
SODIUM ACETATE ANHYDROUS
Quantity: 1.23 mg in 0.5 mL
Code: NVG71ZZ7P0
Class Code: IACT
WATER
Code: 059QF0KO0R
Class Code: IACT
Active Moieties
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
Code: T4GYX3110D
NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
Code: ZT89E5A103
NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
Code: 4WAN8PQK15
NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
Code: L77OK410KW